NAII

+ Watchlist + Portfolio

Natural Alternatives International, Inc.

Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $1.44
52-Week Range: $1.28 – $4.96
Market Cap: $9.27M
P/E (TTM): —
EPS (TTM): -3.43
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 0.14
PEG Ratio: 5.41
Return on Equity: -34.96%
Return on Assets: -3.73%
Gross Margin: 6.31%
Operating Margin: -7.89%
Profit Margin: -14.52%
Current Ratio: 1.74
Debt/Equity: 1.00
Total Debt: $49.97M
Free Cash Flow: $-13.27M
Revenue Growth: 1.90%
Earnings Growth: —
Enterprise Value: $51.57M

NAII Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$170.97M	$154.01M	$113.80M	$129.86M
Cost of Revenue	$140.46M	$135.86M	$106.93M	$120.57M
Gross Profit	$30.51M	$18.16M	$6.87M	$9.29M
Selling, General & Admin	$16.95M	$14.87M	$15.40M	$16.55M
Operating Expenses	$16.83M	$13.45M	$15.40M	$16.55M
Operating Income	$13.68M	$4.71M	-$8.53M	-$7.26M
EBITDA	$17.91M	$8.26M	-$4.46M	-$5.26M
Pretax Income	$13.66M	$3.56M	-$9.46M	-$10.74M
Income Tax	$2.95M	$1.03M	-$2.25M	$2.83M
Net Income	$10.71M	$2.52M	-$7.22M	-$13.57M
Diluted EPS	1.74	0.43	-1.23	-2.28
Diluted Shares	6.16M	5.88M	5.87M	5.95M

NAII Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$21.83M	$13.60M	$11.98M	$12.32M
Receivables	$17.49M	$7.33M	$16.89M	$14.92M
Inventory	$32.48M	$29.69M	$24.25M	$24.87M
Current Assets	$76.75M	$57.01M	$61.61M	$59.28M
Total Assets	$146.00M	$134.15M	$162.34M	$151.94M
Current Liabilities	$23.89M	$15.88M	$23.46M	$28.80M
Long-Term Debt	$9.49M	$9.21M	$8.93M	$8.63M
Total Debt	$31.84M	$30.93M	$60.29M	$59.03M
Total Liabilities	$57.48M	$45.38M	$79.75M	$83.51M
Retained Earnings	$77.66M	$80.18M	$72.97M	$59.39M
Shareholders' Equity	$88.52M	$88.77M	$82.59M	$68.43M
Working Capital	$52.85M	$41.13M	$38.15M	$30.47M
Net Debt	—	—	$648.00K	—

NAII Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$11.87M	$7.02M	-$1.50M	$5.93M
Capital Expenditure	-$26.49M	-$13.52M	-$3.02M	-$3.61M
Free Cash Flow	-$14.62M	-$6.50M	-$4.51M	$2.32M
Depreciation & Amortisation	$4.17M	$4.25M	$4.65M	$4.56M
Stock-Based Compensation	$968.00K	$1.01M	$1.20M	$977.00K
Investing Cash Flow	-$26.46M	-$13.47M	-$3.02M	-$3.61M
Financing Cash Flow	$4.29M	-$1.78M	$2.89M	-$1.97M
Share Repurchases	-$5.50M	-$1.50M	-$221.00K	-$178.00K
Net Change in Cash	-$10.30M	-$8.23M	-$1.62M	$344.00K

NAII Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$28.77M	$33.87M	$37.73M	$34.80M	$35.48M
Cost of Revenue	$26.94M	$30.33M	$33.33M	$32.30M	$35.10M
Gross Profit	$1.83M	$3.54M	$4.40M	$2.49M	$383.00K
Selling, General & Admin	$3.93M	$4.08M	$4.11M	$4.34M	$4.40M
Operating Expenses	$3.93M	$4.08M	$4.11M	$4.34M	$4.40M
Operating Income	-$2.10M	-$544.00K	$284.00K	-$1.85M	-$4.01M
EBITDA	-$1.26M	-$1.45M	$1.19M	-$939.00K	-$2.78M
Pretax Income	-$2.64M	-$2.82M	-$199.00K	-$2.33M	-$4.24M
Income Tax	-$456.00K	$4.40M	$92.00K	$224.00K	$68.00K
Net Income	-$2.19M	-$7.22M	-$291.00K	-$2.55M	-$4.31M
Diluted EPS	-0.37	—	-0.05	-0.42	-0.72
Diluted Shares	5.94M	—	6.01M	6.01M	6.03M

NAII Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$10.61M	$12.32M	$7.74M	$3.75M	$9.20M
Receivables	$13.01M	$14.92M	$19.10M	$17.88M	$20.66M
Inventory	$26.99M	$24.87M	$30.65M	$33.43M	$29.93M
Current Assets	$58.52M	$59.28M	$65.05M	$61.52M	$63.99M
Total Assets	$154.94M	$151.94M	$156.94M	$153.30M	$154.88M
Current Liabilities	$23.31M	$28.80M	$33.90M	$32.85M	$39.13M
Long-Term Debt	$8.70M	$8.63M	$8.55M	$8.47M	$8.39M
Total Debt	$58.43M	$59.03M	$58.93M	$61.71M	$65.17M
Total Liabilities	$78.33M	$83.51M	$87.92M	$86.25M	$91.77M
Retained Earnings	$66.61M	$59.39M	$59.10M	$56.55M	$52.24M
Shareholders' Equity	$76.62M	$68.43M	$69.02M	$67.05M	$63.11M
Working Capital	$35.21M	$30.47M	$31.15M	$28.67M	$24.87M
Net Debt	$396.00K	—	$3.57M	$10.83M	$9.51M

NAII Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$5.99M	$3.35M	-$4.02M	-$6.33M	$2.50M
Capital Expenditure	-$802.00K	-$1.46M	-$1.03M	-$934.00K	-$1.10M
Free Cash Flow	$5.19M	$1.89M	-$5.05M	-$7.26M	$1.40M
Depreciation & Amortisation	$1.14M	$1.16M	$1.17M	$1.17M	$1.19M
Stock-Based Compensation	$245.00K	$179.00K	$177.00K	$178.00K	$140.00K
Investing Cash Flow	-$802.00K	-$1.46M	-$1.03M	-$934.00K	-$1.10M
Financing Cash Flow	-$3.24M	-$176.00K	$472.00K	$3.27M	$4.04M
Share Repurchases	-$168.00K	-$2.00K	-$5.00K	$0.00	-$82.00K
Net Change in Cash	$1.95M	$1.71M	-$4.58M	-$3.99M	$5.44M

Market Snapshot

About

Natural Alternatives International, Inc. is a contract manufacturer specializing in nutritional supplements and related products. The company provides formulation, manufacturing, packaging, and quality testing services for brands in the nutrition industry.